Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tetratricopeptide repeat domain 9C (TTC9C) is a protein encoded by the TTC9C gene in humans and found across species, characterized by the presence of tetratricopeptide repeats (structural motifs of ~34 amino acids facilitating protein-protein interactions)[2][3][4]. TTC9C functions primarily as a scaffold for protein interactions and plays important roles in cilium assembly, left/right asymmetry of the heart, and otolith morphogenesis[1][5]. It has been specifically implicated in intraflagellar transport processes in ciliogenesis and associates with components of the IFT complexes and BBSome, which are essential for cilia formation and motility[5]. Loss of function mutations in TTC9C orthologs in model organisms lead to ciliopathy-like developmental defects, but evidence for direct involvement in human disease remains limited[1][5]. There are currently no approved drugs targeting TTC9C, and it is not considered a standard therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tetratricopeptide repeat domain 9C (TTC9C).